Suraksha Diagnostic Limited IPO Demand Graph
Get Real-Time Updates on stock market trends and news
Get updates on stock market, Stock related news, Algo Trading, learn profitable strategies.
Join WhatsApp ChannelSuraksha Diagnostic Limited IPO
Pre-Apply with Upstox
Frequently Asked Question
You will not receive allotted suraksha diagnostic pvt ltd shares, your IPO application fee will be released or credited back to your bank account through which you applied for this IPO.
Face value of equity shares of Suraksha Diagnostic Limited IPO is ₹1.
The meaning of "suraksha diagnostic limited ipo gmp" is the Grey Market Premium (GMP) for the initial public offering (IPO) of Suraksha Diagnostic Limited IPO on the current day.
Suraksha Diagnostic Limited IPO shares will get listed at NSE, BSE.
You will receive your allocated shares in your Demat account on 04 December 2024.
Pre-issue shareholdings of suraksha technologies limited market promoters are 61.07%.
Post-issue shareholdings of Suraksha Diagnostic Limited IPO promoters are [.]%
You can apply for an IPO anywhere online because it is an online process. You can apply for an IPO through 2 methods ie. ASBA and UPI. The ASBA service is provided by your bank and the UPI service is provided by your stockbroker. Using any of these options you can invest in Suraksha Diagnostic Limited IPO at your convenience, in suraksha diagnostic limited ipo by using any one of these methods at your convenience.
The market lot size of Suraksha Diagnostic Limited IPO is 101 shares.
Suraksha Diagnostic Limited IPO is going to open on 29 November 2024.
The price of 1 share of about suraksha diagnostic private limited ranges from ₹420 to ₹441.
Suraksha Diagnostic Limited IPO will get listed on December 06, 2024.
Bigshare Services Pvt Ltd is the registrar of Suraksha Diagnostic Limited IPO.
Suraksha Diagnostic Limited IPO will be closed on 03 December 2024.
Suraksha Diagnostic Limited IPO customer care customer care number is 033-6619-1000.
Comments for Suraksha Diagnostic Limited IPO Demand Graph
0 comments